ICER releases draft evidence report on treatment for narcolepsy

ICER

12 March 2026 - Public comment period now open until 7 April 2026; requests to make oral comment during public meeting also being accepted.

The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of oveporexton (Takeda) for narcolepsy type 1.

Read ICER Announcement

Michael Wonder

Posted by:

Michael Wonder